Rite Aid Corporation NYSE:RAD - The Resurrection Of Rite Aid Bank of America Merrill Lynch initiated coverage of Rite Aid Corporation RAD 1.41% with a Buy and an $11 price target on the stock. Despite prior struggles, analyst Robert Willoughby said that Rite Aid's "growth is improving" and that the company has returned to acquisitions as a "driver." Rite Aid has also benefited from Walgreens Boots Alliance Inc WBA 0.42% "ill-conceived dispute" with Express Scripts Holding Company ESRX 0.29%, which helped Rite Aid get sales from prescriptions. Willoughby applauded Rite Aid's return to... More